SEARCH

SEARCH BY CITATION

References

  • 1
    Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2): 41994.
  • 2
    Buller HR, Shone M, Middeldorp S. Treatment of venous thromboembolism. J Thromb Haemost 2005; 3: 155460.
  • 3
    Mueller RL, Scheidt S. History of drugs for thrombotic disease. Discovery, development, and directions for the future. Circulation 1994; 89: 43249.
  • 4
    Wardrop D, Keeling D. The story of the discovery of heparin and warfarin. Br J Haematol 2008; 141: 75763.
  • 5
    Deykin D. Antithrombotic therapy in historical perspective. Am J Cardiol 1990; 65: 2C6C.
  • 6
    Ansell JE. Oral anticoagulant therapy 50 years later. Arch Intern Med 1993; 153: 58696.
  • 7
    Dalen JE. Pulmonary embolism: what have we learned since Virchow?: treatment and prevention. Chest 2002; 122: 180117.
  • 8
    Dexter L. The chair and venous thrombosis. Trans Am Clin Climatol Assoc 1973; 84: 115.
  • 9
    de Saint Pathus G. La vie et les Miracles de Saint Louis. Paris: Bibliothèque National de France, 133050.
  • 10
    Brenner B. Did Jesus Christ die of pulmonary embolism? J Thromb Haemost 2005; 3: 21301.
  • 11
    Saliba WR. Did Jesus Christ die of pulmonary embolism? J Thromb Haemost 2006; 4: 8912.
  • 12
    Ur Rehman H. Did Jesus Christ die of pulmonary embolism? A rebuttal. J Thromb Haemost 2005; 3: 21313.
  • 13
    Avicenna (Translated by Abdorrahman Sharafkandi). Avicenna's Canon of Medicine, 1025, 5th edition. Teheran: Soroush Publications, 2008.
  • 14
    Bikedli B, Sharif-Kashani B. Venous thromboembolism: a Persian Perspective to Prevention, Diagnosis, and Treatment. North American Thrombosis Forum 2010. http://www.natfonline.org/media/15133/persianvteperspectiveformat.pdf. Accessed 20 September 2012
  • 15
    Mannucci PM. Venous thrombosis: the history of knowledge. Pathophysiol Haemost Thromb 2002; 32: 20912.
  • 16
    Deslandes M. Traité des Accouchements. Paris: M Puzos Desaint et Saillant, 1759.
  • 17
    White CW. An inquiry into the nature and cause of that swelling in one or both of the lower extremities which sometimes happen to in-lying women together with the propriety of drawing the breasts of those who do and also who do not give suck. London: Warrington, 1784.
  • 18
    Rosendaal FR, Causes of venous thrombosis. In: van Beek EJ, Büller HR, Oudkerk M, eds. Deep Vein Thrombosis and Pulmonary Embolism. Chichester: John Wiley & Sons, 2009.
  • 19
    Moliere JB. Le Malade imaginaire (1673). http://wwwinlibroveritasnet/telecharger/pdf_domaine_public/oeuvre377htm Accessed 20 September 2012.
  • 20
    Piorry P. Traité de Médecine Pratique et de pathologie iatrique ou Médicale. Paris: Librairie Pourchet, 1842.
  • 21
    Parapia LA. History of bloodletting by phlebotomy. Br J Haematol 2008; 143: 4905.
  • 22
    Wright IS. Thrombophlebitis. Bull N Y Acad Med 1941; 17: 34872.
  • 23
    Bagot CN, Ayra R. Virchow and his triad: a question of attribution. Br J Haematol 2008; 143: 18090.
  • 24
    Barral F. Vena cava filters: why, when, what and how? J Cardiovasc Surg 2008; 49: 3549.
  • 25
    Holden WD. Treatment of deep venous thrombosis with reference to subcutaneous injection of heparin and use of dicumarol. Arch Surg 1947; 54: 1837.
  • 26
    Albright HL. Thrombophlebitis, the problem of treatment. N Engl J Med 1947; 236: 92833.
  • 27
    Crane C. Deep venous thrombosis and pulmonary embolism; experience with 391 patients treated with heparin and 126 patients treated by venous division, with a review of the literature. N Engl J Med 1957; 257: 14757.
  • 28
    Rainal Frères (experts de l'assistance publique). Catalogue général 1825–1934. Paris: Bouttin, 1934.
  • 29
    Amat C. Leçons de Clinique thérapeutique du Professeur Albert Robin: le traitement des phlébites. Bulletin général de thérapeutique médicale, chirurgicale, obstétricale et pharmaceutique 1905; 149: 692736.
  • 30
    Vaquez LH. Conduite à tenir dans les cas de phlébite. Gazette hebdomadaire de médecine et de Chirurgie 1900; 93: 556.
  • 31
    Breschet G. Traité des maladies des artères et des veines de J Hodgson. Traduit de l'anglais et augmenté d'un grand nombre de notes. Nouveau Journal de Médecine, Pharmacie 1819; 6: 27983.
  • 32
    Whitaker IS, Izadi D, Oliver DW, Monteath G, Butler PE. Historical article: Hirudo medicinalis: ancient origins of, and trends in the use of medicinal leeches throughout history. Br J Oral Maxillofac Surg 2004; 42: 1337.
  • 33
    Dance D. Phlébite générale et phlébite uterine. Archives générales de Médecine 1828; 1: 2869.
  • 34
    Bauer G. Thrombosis; early diagnosis and abortive treatment with heparin. Lancet 1946; 1: 44754.
  • 35
    Homans J. Thrombophlebitis of the lower extremities. Ann Surg 1928; 87: 64151.
  • 36
    Dickinson B. Virchow's triad? South Med J 2004; 97: 91516.
  • 37
    McLean J. The discovery of heparin. Circulation 1959; 19: 758.
  • 38
    Charles AF, Scott DA. Studies on heparin: observations on the chemistry of heparin. Biochem J 1936; 30: 192733.
  • 39
    Murray DW, Jaques LB, Perrett TS, Best CH. Heparin and thrombosis of the veins following injury. Surgery 1937; 2: 16387.
  • 40
    Crafoord C. Preliminary report on post-operative treatment with heparin as a preventive of thrombosis. Acta Chir Scand 1937; 79: 40726.
  • 41
    Murray GD, Best CH. The use of heparin in thrombosis. Ann Surg 1938; 108: 16377.
  • 42
    Bauer G. Nine years’ experience with heparin in acute venous thrombosis. Angiology 1950; 1: 1619.
  • 43
    Link KP. The discovery of dicumarol and its sequels. Circulation 1959; 19: 97107.
  • 44
    Prandoni A, Wright I. The anti-coagulants: heparin and the dicoumarin-3,3′-methylene-Bis-(4-hydroxycoumarin). Bull N Y Acad Med 1942; 18: 43358.
  • 45
    Meissner MH, Moneta G, Burnand K, Gloviczki P, Lohr JM, Lurie F, Mattos MA, McLafferty RB, Mozes G, Rutherford RB, Padberg F, Sumner DS. The hemodynamics and diagnosis of venous disease. J Vasc Surg 2007; 46: 4S24S.
  • 46
    Schwartz A. La semaine du clinicien. Affections inflammatoires: les phlébites. Paris Médical 1924; 51: 4456.
  • 47
    Maladies du Coeur et des vaisseaux; le traitement des phlebites par une nouvelle méthode. Bulletin général de thérapeutique médicale, chirurgicale, obstétricale et pharmaceutique 1905; 150: 31617.
  • 48
    Marks J, Truscott BM, Withycombe JF. Treatment of venous thrombosis with anticoagulants; review of 1135 cases. Lancet 1954; 267: 78791.
  • 49
    Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 67781.
  • 50
    Partsch H, Blättler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000; 32: 8619.
  • 51
    Schellong S, Schwarz T, Kropp J, Prescher Y, Beuthien-Baumann B, Daniel WG. Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism. Thromb Haemost 1999; 82: 1279.
  • 52
    Aschwanden M, Labs KH, Engel H, Schwob A, Jeanneret C, Mueller-Brand J, Jaeger KA. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 2001; 85: 426.
  • 53
    Hyers TM. Management of venous thromboembolism: past, present, and future. Arch Intern Med 2003; 163: 75968.
  • 54
    Boccalon H, Elias A, Chalé JJ, Cadène A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med 2000; 160: 176973.
  • 55
    Blättler W, Gerlach HE. Implementation of outpatient treatment of deep-vein thrombosis in private practices in Germany. Eur J Vasc Endovasc Surg 2005; 30: 31924.
  • 56
    DeWeese J. Treatment of venous disease – the innovators. J Vasc Surg 1994; 20: 67583.
  • 57
    Hohlbaum G-G. Historique de la compression Médicale. In: Gardon-Mollard C, Ramelet AA, eds. La compression Médicale. Paris: Abrégés de Médecine Editions Masson, 2006.
  • 58
    Brandjes DP, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 75962.
  • 59
    Moretz WH, Nasibitt PF, Stevenson GP. Experimental studies on temporary occlusion of the inferior vena cava. Surgery 1954; 36: 38498.
  • 60
    Dale WA, Pualwan F, Bauer FM. Ligation of the inferior vena cava with absorbable gut. Surg Gynecol Obstet 1956; 102: 51730.
  • 61
    Spencer FC. An experimental evaluation of partitioning of the inferior vena cava to prevent pulmonary embolism. Surg Forum 1960; 10: 6804.
  • 62
    Gardner AM, Harse HR. A self-releasing inferior vena caval clip. Lancet 1967; 7486: 368.
  • 63
    Ravitch MM, Snodgrass E, McEnany T, Rivarola A. A compartmentalization of the vena cava with the mechanical stapler. Surg Gynecol Obstet 1966; 122: 5614.
  • 64
    Miles RM, Chapell F, Renner O. A partially occluding vena caval clip for prevention of pulmonary embolism. Am Surg 1964; 30: 407.
  • 65
    Moretz WH, Rhode C, Shephard MH. Prevention of pulmonary emboli by partial occlusion of the inferior vena cava. Am Surg 1959; 25: 61726.
  • 66
    Adams JT, DeWeese JA. Partial interruption of the inferior vena cava with a new plastic clip. Surg Gynecol Obstet 1966; 123: 10878.
  • 67
    Cain PG. Comment on ‘Treatment of venous disease – the innovators’. J Vasc Surg 1995; 22: 3413.
  • 68
    Mobin-Uddin K, Smith PE, Martinez LO, Lombardo CR, Jude JR. A vena caval filter for the prevention of pulmonary embolus. Surg Forum 1967; 18: 20911.
  • 69
    Greenfield LJ. Historical reminiscence: origin of the Greenfield filter. Am Surg 2010; 76: 131920.
  • 70
    Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338: 40915.
  • 71
    Kaufman JA. Optional vena cava filters: what, why, and when. Vascular 2007; 15: 30413.
  • 72
    Eichelter P, Schenk W Jr. Prophylaxis of pulmonary embolism. A new experimental appraoch with initial results. Arch Surg 1968; 97: 34856.
  • 73
    Eklöf B. Charles Rob, Alfred Nobel and Aphrodite: the development of surgery for venous thromboembolism. Cardiovasc Surg 1994; 2: 18794.
  • 74
    Mahorner H, Castelberry JW, Coleman WO. Attempts to restore function in major veins which are the site of massive thrombosis. Ann Surg 1957; 146: 51022.
  • 75
    Fontaine R. Remarks concerning venous thrombosis and its sequelae. Surgery 1957; 41: 625.
  • 76
    Fogarty TJ, Cranley JJ, Krause RJ, Strasser ES, Hafner CD. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet 1963; 116: 2414.
  • 77
    Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379: 318.
  • 78
    Sherry S. The origin of thrombolytic therapy. J Am Coll Cardiol 1989; 14: 108592.
  • 79
    Christensen LR. Protamine purification of streptokinase and effect of pH and temperature on reversible inactivation. J Gen Physiol 1947; 30: 46573.
  • 80
    Tillett W, Sherry S, Christensen LR, Johnson A, Hazlehurst G. Streptococcal enzymatic debridement. Ann Surg 1949; 131: 1222.
  • 81
    Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodomase in the treatment of postpneumonic empyema. J Thorac Surg 1951; 21: 27597.
  • 82
    Cliffton E. The use of plasmin in humans. Ann N Y Acad Sci 1957; 30: 20929.
  • 83
    Ambrus JL, Ambrus CM, Back N, Sokal JE, Collins GL. Clinical and experimental studies on fibrinolytic enzymes. Ann N Y Acad Sci 1957; 68: 97136.
  • 84
    Marder V. Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin. J Thromb Haemost 2011; 9: 36473.
  • 85
    Kakkar VV, Flanc C, Howe CT, O'Shea M, Flute PT. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. Br Med J 1969; 1: 80610.
  • 86
    Schulman S, Granqvist S, Juhlin-Dannfelt A, Lockner D. Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase. Acta Med Scand 1986; 219: 34957.
  • 87
    Kahn SR. How I treat postthrombotic syndrome. Blood 2009; 114: 462431.
  • 88
    Prandoni P. Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants. Eur J Haematol 2012; 88: 18594.
  • 89
    Baglin T. Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins? J Thromb Haemost 2012; 10: 17023.
  • 90
    Birnbaum Y, Luo H, Nagai T, Fishbein MC, Peterson TM, Li S, Kricsfeld D, Porter TR, Siegel RJ. Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 1998; 97: 1304.
  • 91
    Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, WARFASA Investigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012; 366: 195967.
  • 92
    Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360: 15161.
  • 93
    Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, Prins MH, Girolami A. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 143541.